Wedmont Private Capital’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
9,217
+1,708
+23% +$483K 0.07% 142
2026
Q1
$2.08M Buy
7,509
+95
+1% +$26.3K 0.07% 161
2025
Q4
$2.07M Buy
7,414
+1,031
+16% +$289K 0.07% 156
2025
Q3
$1.96M Buy
6,383
+122
+2% +$36.1K 0.07% 167
2025
Q2
$1.94M Buy
6,261
+1,603
+34% +$517K 0.08% 148
2025
Q1
$1.54M Sell
4,658
-6
-0.1% -$1.81K 0.08% 153
2024
Q4
$1.3M Buy
4,664
+373
+9% +$119K 0.07% 177
2024
Q3
$1.46M Buy
4,291
+105
+3% +$36.1K 0.08% 146
2024
Q2
$1.4M Buy
4,186
+316
+8% +$109K 0.09% 141
2024
Q1
$1.38M Buy
3,870
+154
+4% +$50.7K 0.1% 131
2023
Q4
$1.17M Buy
3,716
+297
+9% +$86.8K 0.1% 138
2023
Q3
$990K Buy
3,419
+801
+31% +$228K 0.1% 128
2023
Q2
$740K Buy
2,618
+772
+42% +$201K 0.08% 172
2023
Q1
$486K Sell
1,846
-481
-21% -$140K 0.06% 229
2022
Q4
$704K Buy
2,327
+396
+21% +$125K 0.11% 148
2022
Q3
$536K Buy
1,931
+451
+30% +$127K 0.11% 153
2022
Q2
$390K Buy
1,480
+355
+32% +$91.5K 0.08% 174
2022
Q1
$273K Buy
+1,125
New +$263K 0.06% 252

Other funds holding CI

Wedmont Private Capital's CI Position: Q2 2026 in Review

Wedmont Private Capital increased its Cigna (CI) stake by 23% in Q2 2026, buying an estimated $483K and bringing the position to 9,217 shares worth $2.7M. The position accounts for 0.07% of the portfolio, ranked #142.

Wedmont Private Capital first reported a position in CI in Q1 2022 and has held it in 18 quarters since. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Wedmont Private Capital held 9,217 shares of Cigna worth $2.7M as of Q2 2026.
  • Wedmont Private Capital bought 1,708 Cigna shares in Q2 2026, an estimated $483K.
  • Cigna made up 0.07% of Wedmont Private Capital's portfolio in Q2 2026, its #142 holding.
  • Wedmont Private Capital first reported a position in Cigna in Q1 2022 and has held it in 18 quarters since.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.